Synergen Incorporated

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Contact Details: 1885 33rd Street Boulder CO 80301 United States of America Tel: 303 938 6207 Fax: 303 938 6268 Email:

Loading...

Recent Publications by Synergen Incorporated:
Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells. PURPOSE: Enzastaurin (LY317615) is a novel serine/threonine kinase...	15th November, 2007	St. Georg Hospital, Lohmuhlenstr. 5, 20099 Hamburg, Germany.	Invest New Drugs. 2008 Jun;26(3):215-22. Epub 2007 Nov 14. DOI Direct Link
In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression. AIM OF THE STUDY: mRNA expression of genes involved in the mechanism of...	6th November, 2007	Asklepios Klinik, St. Georg, Lohmuhlenstr. 5, 20099 Hamburg, Germany.	Invest New Drugs. 2007 Oct;25(5):417-23. Epub 2007 May 30. DOI Direct Link
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors. PURPOSE: Erlotinib (Tarceva) is a potent epidermal growth factor receptor...	25th April, 2007	Department of Medicine, Asklepios Hospital St. Georg, D-20099 Hamburg,	Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):523-31. DOI Direct Link
Translational research with pemetrexed in breast cancer. Pemetrexed (Alimta) is a novel folate antimetabolite that primarily...	4th February, 2005	AK St. Georg, Department of Medicine, Hamburg, Germany.	Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):66-9.
Overview of phase I/II pemetrexed studies. Pemetrexed (Alimta) is an antifolate that is effective in the inhibition...	4th February, 2005	AK St. Georg, Department of Medicine, Hamburg, Germany.	Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):18-25.
→View more Synergen Incorporated research publications.

BioNews Results for Synergen Incorporated:
Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and S	Pharma Live:  May 28 2008 2:08PM Matching: synergen

Synergen Incorporated Patents:
US Patent No.	Title
5459048	DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals
4760130	Serine protease inhibitors and methods for isolation of same
4994559	Human basic fibroblast growth factor
4997929	Purified ciliary neurotrophic factor
5026839	DNA encoding a basic fibroblast growth factor
→View more Synergen Incorporated patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Synergen Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 354 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: synergen pharma inc. | synergen pharma inc. | medicines of synergen | klinik st georg lohmuhlenstr 5 hamburg | synergen | SYNERGEN Incorporated | synergen | synergen | Synergen Pharma Inc. | Synergen Pharma | .

Search for more companies in Boulder

Search for more companies in CO

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Synergen Incorporated

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.